Stock ALCLS CELLECTIS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

All News Cellectis S.A.

Equities

ALCLS

FR0010425595

Real-time Euronext Paris
Other stock markets
 08:34:02 2024-04-30 am EDT 		5-day change 1st Jan Change
2.44 EUR -0.41% Intraday chart for Cellectis S.A. +0.83% -11.72%
Apr. 29 Cellectis S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 29 Cellectis S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cellectis S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
GL
Cellectis S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%
MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
MT
Cellectis Presents Novel TALEN Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
AQ
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
GL
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
CI
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading
MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
MT
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
MT
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
MT
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
GL
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
MT
Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual Meeting
GL
Cellectis S A : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
PU
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading
MT
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALCLS Stock
  4. News Cellectis S.A.